Published in Cancer Weekly, October 19th, 2004
The presentation, made by Dr. Andrew Evens of the hematology/oncology department at Northwestern University's Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center in Chicago, Illinois, also included laboratory studies providing evidence that Xcytrin localizes in lymphoma cells, generates reactive oxygen species, and induces...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.